DiaMedica Therapeutics Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Operating income | -$34.4 | -$26.7 | -$21.3 | -$14.0 | -$13.6 |
| Net income | -$32.8 | -$24.4 | -$19.4 | -$13.7 | -$13.6 |
| Cash Flow Statement | |||||
| Free cash flow | -$29.1 | -$22.1 | -$18.8 | -$11.6 | -$12.3 |
Shares outstanding 53.9M · Free float 45.8%
Annual filing data through FY ended December 31, 2025; float as of August 26, 2026.